TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Thor Life Science Consulting AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
0
|
0
|
1,445 |
| Financial expenses |
7
|
14
|
0 |
| Earnings before taxes |
66
|
-9
|
953 |
| EBITDA |
-16
|
-20
|
952 |
| Total assets |
1,333
|
1,496
|
1,683 |
| Current assets |
1,333
|
1,496
|
1,666 |
| Current liabilities |
-6
|
163
|
345 |
| Equity capital |
1,320
|
1,313
|
1,316 |
| - share capital |
32
|
34
|
33 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
99.0%
|
87.8%
|
78.2% |
| Turnover per employee |
0
|
0
|
1,445 |
| Profit as a percentage of turnover | 66.0% | ||
| Return on assets (ROA) |
5.5%
|
0.3%
|
56.6% |
| Current ratio |
-22216.7%
|
917.8%
|
482.9% |
| Return on equity (ROE) |
5.0%
|
-0.7%
|
72.4% |
| Change turnover |
0
|
-1,452
|
517 |
| Change turnover % |
-100%
|
56% | |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.